AIM

AIM ImmunoTech Inc.

20 hedge funds and large institutions have $2.57M invested in AIM ImmunoTech Inc. in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$960K 1,391,286 +39,436 +3%
AFM
2
Anson Funds Management
Texas
$739K 1,071,627 -241,061 -18%
BIT
3
BlackRock Institutional Trust
California
$331K 479,701 +2 +0%
Vanguard Group
4
Vanguard Group
Pennsylvania
$296K 429,697 -34,534 -7%
Renaissance Technologies
5
Renaissance Technologies
New York
$97K 139,952 -18,200 -12%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$51K 74,832 +1 +0%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$39K 57,091 +57,091 New
OAM
8
Occidental Asset Management
California
$11K 15,834
Northern Trust
9
Northern Trust
Illinois
$11K 17,111 +140 +0.8%
PAM
10
Panagora Asset Management
Massachusetts
$8K 11,353
UBS Group
11
UBS Group
Switzerland
$7K 10,200 +6,716 +193%
WPW
12
Waldron Private Wealth
Pennsylvania
$7K 11,000 +11,000 New
BFA
13
BlackRock Fund Advisors
California
$5K 6,904 +1,620 +31%
BA
14
BlackRock Advisors
Delaware
$4K 5,727
VKH
15
Virtu KCG Holdings
New York
-10,337 Closed
JCM
16
Jacobi Capital Management
Pennsylvania
-55 Closed
CHC
17
City Holding Co
West Virginia
$0 417
LTFS
18
Ladenburg Thalmann Financial Services
Florida
$0 80
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$0 216
BlackRock
20
BlackRock
New York
$0 42
Deutsche Bank
21
Deutsche Bank
Germany
$0 24
Creative Planning
22
Creative Planning
Kansas
$0 5 +5 New